SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026308
Filing Date
2021-05-11
Accepted
2021-05-11 08:15:54
Documents
51
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q prld-10q_20210331.htm 10-Q 3057912
2 EX-31.1 prld-ex311_11.htm EX-31.1 20892
3 EX-31.2 prld-ex312_7.htm EX-31.2 20902
4 EX-32.1 prld-ex321_9.htm EX-32.1 10238
5 EX-32.2 prld-ex322_8.htm EX-32.2 10313
  Complete submission text file 0001564590-21-026308.txt   5855657

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT prld-20210331.xml EX-101.INS 697744
7 XBRL TAXONOMY EXTENSION SCHEMA prld-20210331.xsd EX-101.SCH 31758
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prld-20210331_cal.xml EX-101.CAL 27272
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prld-20210331_def.xml EX-101.DEF 130623
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE prld-20210331_lab.xml EX-101.LAB 266945
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prld-20210331_pre.xml EX-101.PRE 207973
Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-39527 | Film No.: 21909716
SIC: 2834 Pharmaceutical Preparations